Market cap
₹34 Cr
Recently Viewed
Clear AllMarket cap
₹34 Cr
Revenue (TTM)
₹38 Cr
P/E Ratio
8.4
P/B Ratio
1.2
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹4 Cr
ROE
18.1 %
ROCE
17 %
Industry P/E
37.18
EV/EBITDA
6.3
Debt to Equity
0.4
Book Value
₹25.1
EPS
₹3.5
Face value
10
Shares outstanding
11,700,000
CFO
₹-9.92 Cr
EBITDA
₹16.05 Cr
Net Profit
₹8.04 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medicamen Organics
| 21.7 | 25.6 | 16.3 | 7.0 | -- | -- | -- |
|
BSE Healthcare
| 6.4 | 11.7 | 9.7 | 9.1 | 26.0 | 14.0 | 11.5 |
|
Company
|
2025
|
|---|---|
|
Medicamen Organics
| -55.1 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medicamen Organics
|
29.2 | 34.2 | 38.2 | 4.1 | -- | 18.1 | 8.4 | 1.2 |
| 1,125.0 | 13,788.8 | 2,512.3 | 543.7 | 28.3 | 19.3 | 25.4 | 4.4 | |
| 489.5 | 8,472.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 28.9 | 6.5 | |
| 1,222.0 | 12,795.1 | 1,158.7 | 309.6 | 31.9 | 17.3 | 40.9 | 6.8 | |
| 1,659.5 | 31,471.9 | 9,203.5 | 941.3 | 15.4 | 19.6 | 34 | 6.4 | |
| 378.2 | 4,125.4 | 159.3 | 47.8 | 39.0 | 18.6 | 86.3 | 14.9 | |
| 17,032.0 | 21,774.5 | 1,575.1 | 179.1 | 14.9 | 11.4 | 121.6 | 13.1 | |
| 915.7 | 4,229.3 | 588.5 | 102.9 | 22.1 | 12.7 | 41.6 | 5.0 | |
| 674.7 | 7,617.8 | 502.0 | 138.7 | -- | 32.8 | 54.9 | 8.8 | |
| 213.5 | 5,637.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.5 |
No Review & Analysis are available.
--
Incorporated
1995
Chairman
--
Managing Director
Bal Kishan Gupta
Headquarters
New Delhi, Delhi
Website
Looking for more details about Medicamen Organics Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Medicamen Organics Ltd is ₹29.20 (NSE) as of 06-May-2026 IST. Medicamen Organics Ltd has given a return of 6.96% in the last 1 years.
The P/E ratio of Medicamen Organics Ltd is 8.44 times as on 06-May-2026, a 77 discount to its peers’ median range of 37.18 times.
The P/B ratio of Medicamen Organics Ltd is 1.16 times as on 06-May-2026, a 72 discount to its peers’ median range of 4.20 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
6.27
|
0.86
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Medicamen Organics Ltd are Rs 49.70 and Rs 20.05 as of 06-May-2026.
Medicamen Organics Ltd has a market capitalisation of ₹ 34 Cr as on 06-May-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Medicamen Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.